More tools:Markets·Screener·Research·Chat

BioVie, Inc. Common Stock (BIVI) Financial Statements

BioVie, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00548BTF4
XNAS · usd
2.07▲ 0.07 (3.50%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close2.00
Day's Range2.00 – 2.20
52-Week Range0.82 – 3.79
Volume317.7K
Avg Volume8.5M
Share Statistics
Shares Outstanding
Employees13
ExchangeXNAS
Listed2014-01-14
Share count as of August 10, 2026
Loading Income Statement…
Key questions about BioVie, Inc. Common Stock (BIVI)
What is BioVie, Inc. Common Stock's Market Cap?
BioVie, Inc. Common Stock's Market Cap is $15.6M, based on as-reported figures from SEC (XBRL) filings.
What is BioVie, Inc. Common Stock's Enterprise Value?
BioVie, Inc. Common Stock's Enterprise Value is $6.6M, based on as-reported figures from SEC (XBRL) filings.
What is BioVie, Inc. Common Stock's EV / EBITDA?
BioVie, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is BioVie, Inc. Common Stock's Net Income (TTM)?
BioVie, Inc. Common Stock's Net Income (TTM) is -$22.1M, based on as-reported figures from SEC (XBRL) filings.
What is BioVie, Inc. Common Stock's EBITDA?
BioVie, Inc. Common Stock's EBITDA is -$22.5M, based on as-reported figures from SEC (XBRL) filings.
What is BioVie, Inc. Common Stock's Diluted EPS (TTM)?
BioVie, Inc. Common Stock's Diluted EPS (TTM) is -2.93, based on as-reported figures from SEC (XBRL) filings.
What is BioVie, Inc. Common Stock's Net Debt?
BioVie, Inc. Common Stock's Net Debt is -$9.0M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
OPERATING EXPENSES:
Amortization of Intangibles
Research and Development Expense
Selling, General and Administrative Expense
TOTAL OPERATING EXPENSES
LOSS FROM OPERATIONS
OTHER (INCOME) EXPENSE:
Change in fair value of derivative liabilities——
Interest Expense
Interest income
TOTAL OTHER INCOME, NET
NET LOSS
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
Earnings Per Share (Basic)—
Earnings Per Share (Diluted)—